ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2015–2016
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Cancer Drugs
Clinical Cancer Drugs is not currently indexed in Scopus. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2212-697XVerify ISSN ↗2212-6988Verify ISSN ↗
Publisher: Bentham Science Publishers
Scopus · InactiveONOS
0
Indexed in
Cost to publish: No APC data — check the publisher
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Clinical Cancer Drugs indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2015–2016).
What is the impact factor of Clinical Cancer Drugs?
Clinical Cancer Drugs has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Clinical Cancer Drugs and what is its ISSN?
Clinical Cancer Drugs is published by Bentham Science Publishers. Its print ISSN is 2212-697X and its online ISSN is 2212-6988.
Is Clinical Cancer Drugs covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Clinical Cancer Drugs in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Clinical Cancer Drugs open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Clinical Cancer Drugs for 2 years, between 2015 and 2016. Coverage ended in 2016, 10 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 193 works and 532 citations for the title. OpenAlex attributes papers to this title as late as 2025, 9 years after Scopus coverage ended in 2016. That may reflect a changed ISSN or merged records rather than continued publishing, so confirm the journal's current status directly before submitting.
How well cited is Clinical Cancer Drugs? — open metrics via OpenAlex
Clinical Cancer Drugs has an h-index of 12 and a 2-year mean of 0.32 citations per paper (OpenAlex).
12
h-index
0.32
2-yr mean citations
14
i10-index
193
works indexed
532
total citations
Clinical Cancer Drugs published 23 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Clinical Cancer Drugs? — latest 66 articles, 2021–2026
In its latest 66 research articles (2021–2026), authors are most often from India (64.4%), Iran (6.1%) and United States (4.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Clinical Cancer Drugs? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2016. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2016
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration64.4% of recent authorship from India
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Journal Scopus status
Adolescent Psychiatry Active Anti-Cancer Agents in Medicinal Chemistry Active Anti-Infective Agents Active Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Active Cardiovascular and Hematological Disorders - Drug Targets Active Central Nervous System Agents in Medicinal Chemistry Active Related journals
8 journals Journal Indexed in
Clinical Immunology, Endocrine and Metabolic Drugs Not in these indexes Clinical Practice and Epidemiology in Mental Health Scopus Q2 CNS and Neurological Disorders - Drug Targets Scopus Q1 WoS SCIE Combinatorial Chemistry and High Throughput Screening Scopus Q2 WoS SCIE Coronaviruses Scopus Q4 Current Aging Science Scopus Q3 Current Alzheimer Research Scopus Q3 WoS SCIE Current Analytical Chemistry Scopus Q3 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.